Microcurrent Stimulation for Dry Age-related Macular Degeneration
Launched by I-LUMEN SCIENTIFIC, INC. · Aug 12, 2020
Trial Information
Current as of August 11, 2025
Withdrawn
Keywords
ClinConnect Summary
Multi-center, double-masked, randomized trial of microcurrent stimulation for the treatment of patients affected with dry age-related macular degeneration.
Gender
ALL
Eligibility criteria
- Key Inclusion Criteria - Study Eye:
- • Dry AMD diagnosis.
- Key Exclusion Criteria - Study Eye:
- • Wet AMD
About I Lumen Scientific, Inc.
i-lumen scientific, inc. is a pioneering clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative study designs and robust data analysis. With a strong focus on ethical practices and regulatory compliance, i-lumen collaborates with healthcare professionals and institutions to facilitate groundbreaking clinical trials across various therapeutic areas. Leveraging cutting-edge technology and a commitment to scientific integrity, the organization strives to expedite the development of new therapies while ensuring the highest standards of safety and efficacy for participants.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Timothy Jackson, MD
Principal Investigator
King's College London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials